Fig. 2From: Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO study): study protocol for a prospective, multicentre, single-arm trialPatients can opt for two dose reductions, leading to a total follow-up of 18 monthsBack to article page